Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity. - Wikidata - awgldk - TriplyDB

Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.

Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.

http://www.wikidata.org/entity/Q36835495

about

Malaria vaccines: identifying Plasmodium falciparum liver-stage targets CD8(+) T cells mediate robust stage-specific immunity to P. berghei under chemoprophylaxis and this protective environment is not downregulated by the presence of blood-stage infection The March Toward Malaria Vaccines External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance Sporozoite immunization of human volunteers under mefloquine prophylaxis is safe, immunogenic and protective: a double-blind randomized controlled clinical trial Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial High Sporozoite Antibody Titers in Conjunction with Microscopically Detectable Blood Infection Display Signatures of Protection from Clinical Malaria Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies.Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.Identification of pre-erythrocytic malaria antigens that target hepatocytes for killing in vivo and contribute to protection elicited by whole-parasite vaccination.Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.Expansion of IgG+ B-cells during mitogen stimulation for memory B-cell ELISpot analysis is influenced by size and composition of the B-cell pool.Sporozoite immunization of human volunteers under chemoprophylaxis induces functional antibodies against pre-erythrocytic stages of Plasmodium falciparum.Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites.A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine.Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization.The case for a rational genome-based vaccine against malaria.Blood-stage immunity to Plasmodium chabaudi malaria following chemoprophylaxis and sporozoite immunization Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.Chloroquine neither eliminates liver stage parasites nor delays their development in a murine Chemoprophylaxis Vaccination model.Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection.Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites.Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection The Power of Malaria Vaccine Trials Using Controlled Human Malaria Infection.Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial.Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.ESAT-6-dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis.Diagnosis and treatment based on quantitative PCR after controlled human malaria infection.Measurement of the T Cell Response to Preerythrocytic Vaccination in Mice.Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccines CD8 T cell independent immunity after single dose infection-treatment-vaccination (ITV) against Plasmodium yoelii.Decreased growth rate of P. falciparum blood stage parasitemia with age in a holoendemic population.Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection.The path of malaria vaccine development: challenges and perspectives.Correlates of protective immunity following whole sporozoite vaccination against malaria.Live attenuated pre-erythrocytic malaria vaccines.

P2860

Q26781372-4038A0D4-BE21-494D-BC43-174CA747F2D0 Q27323125-A3A1CA6D-629C-40E8-8507-91C780322EBD Q28084325-61F82D48-F397-42D1-8CF9-64579AF81BA8 Q28538917-2432B4F6-4D61-420B-8224-20AC44C733DE Q28544964-94E613BB-BA53-4C93-9A67-3E9E4600D3DD Q30991737-C4E3FEB9-69F3-41EE-8F36-10C321F0972F Q33646573-7B05EC56-E613-40E9-B786-CBFCEB0B43E1 Q33744460-7AC88E30-9C54-493A-970B-7067CC061BB0 Q33798074-DD63D0DB-CAE0-48A9-8704-1E72FEBEE0A3 Q33821137-2E95250C-3687-485D-93A2-5D06F934B09B Q33905005-16619CE4-8A0F-47A2-8E09-CE53C070B870 Q33927133-DF5C434E-4FA0-40CC-8946-F58C00AC9266 Q33933486-B4519235-CD77-4A66-9595-CE6403EBA410 Q33960093-363B8098-B715-4592-8FD9-5C8BCD94C647 Q34301461-FC9AF075-FAF1-4E74-AD94-5C7FE28A0523 Q34399831-642B77FE-78EB-4C98-AAA4-6041FF48D6C7 Q34487139-6B808B05-A2CB-4CC3-AA70-9BEA104152B9 Q34563555-5BC92733-F1FC-4317-A7BF-60898D88B447 Q34999392-032D907F-2B9F-408C-B306-F7CDAEF448C1 Q35211003-DF9FAD65-08F2-4C4C-A2AB-18AF5CC55D5C Q35211679-91804874-C727-4115-B8CE-E290752D46D5 Q35336088-0C0C2F7E-74EA-450B-9092-281C7A9E1218 Q35439859-346D3586-88B2-4AC2-904A-4C430BD9689B Q35560599-85E56848-7A24-47D6-B414-31DB7677E84E Q35922955-21FAC18A-DCAB-425A-BB96-9F181B02F506 Q36004060-A6CDA83D-5EF4-4D84-9E06-BD0D126A4DC9 Q36247418-B997C415-F9EC-4B71-80FA-2D200E602E52 Q36644534-1407378A-72D7-4DA7-94F1-280972502077 Q36686924-2789AD14-C25D-47FF-A950-F5BD7D29242C Q36951826-DF5D0381-2702-4F4B-B8C4-85BE02E55DCF Q36972498-EEF307A1-364F-4E05-8A08-D481A171B2E2 Q37154138-CA4DCDB8-E81C-4F21-9CB0-8CA16A59C890 Q37385314-3C11BF76-0270-48D8-8336-354FDB76FDB0 Q37530299-01F61076-9288-4CCA-A54E-E4712331F2E3 Q37581819-D81E3045-752C-4213-AA78-AA1ACB9D8AEB Q37635135-B63C9C4D-FE29-4C89-B3FC-ADB5A8B9B06F Q37641378-69F4DB23-2A4F-4E54-9B1E-A815DFEDAB88 Q38196455-786B6266-9E40-407C-AB65-805047C3F62D Q38211625-0888B60C-08F3-40E8-A319-83A90CADAFEB Q38284696-9CAB10B5-67F9-47BB-9F41-DC395474E9E6

P2860

Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.

http://www.wikidata.org/entity/Q36835495

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Protection against malaria aft ...... d by preerythrocytic immunity.

@en

type

label

Protection against malaria aft ...... d by preerythrocytic immunity.

@en

prefLabel

Protection against malaria aft ...... d by preerythrocytic immunity.

@en

P1433

Q36835495-84E0ECC3-A218-49D6-808F-9D015FB20076

P1476

Q36835495-18D01AF8-D9EB-43EE-B70C-ED43AE02BC3E

P2093

Q36835495-0CFB18FB-9DDB-42CB-A1B0-88604A043A06

Q36835495-121C7D6F-C1AF-4332-BA34-517677B6A376

Q36835495-19EFBE80-A082-420A-BA08-0D98689945BF

Q36835495-2BFFFD6A-03CA-4E7E-853B-29619B134C13

Q36835495-4F6CA9F7-69CB-44AF-906C-73FAA728557E

Q36835495-4FA0FFB2-5188-4BD3-9973-D7DC7E30778A

Q36835495-59095730-13BF-4F50-AB62-7488F4CC6F79

Q36835495-6172E5AD-C710-41C1-A454-E321F9C955D8

Q36835495-AB13E357-9C2F-4DB8-A3A0-9A320A74330F

Q36835495-C1D6CCE3-1B45-46BD-A94A-541EB188F07A

P2860

Q36835495-025D87F7-6931-462C-89BD-F50D721FB597

Q36835495-02CC1F05-04CD-43F0-9761-8037FBF476C0

Q36835495-15F1937B-E585-4C95-AB73-71458A0089CA

Q36835495-19EBCB82-47EA-4D94-9C38-92A29DDDC8A6

Q36835495-1C091B3D-4AB6-4DAD-8C56-9FA1E9D60AAF

Q36835495-1F092FCB-30C3-4F4E-B187-D6523D804BAD

Q36835495-22C5B85F-0D19-4D41-BE31-D2EAD42B56A6

Q36835495-23FB90A9-C6D8-4AC3-8517-6A352E7D8CD9

Q36835495-2716F472-308A-4FD0-B7B0-2632F5ED0C74

Q36835495-2E63A600-C5D4-4307-A196-8DB9F159C696

P304

Q36835495-2843294D-22D0-4E00-99F7-B738B6D45F53

P31

Q36835495-27667BB3-67A2-4FDB-B9FF-8C5C54A1563B

P356

Q36835495-BB9D1716-1A16-4C4E-A8C1-1AEB4872F4A2

P407

Q36835495-6994FB93-F14F-4A83-9C92-177FF8596A92

P433

Q36835495-C106BAEB-CB32-47E4-9E84-7C04E4466355

P478

Q36835495-6E58917A-637C-4B30-9294-596303FC6378

P50

Q36835495-1097774B-98A0-445A-BB49-F48C5D845FDE

Q36835495-2EA3D691-D00B-435B-98D3-70642A183660

Q36835495-553F1131-6669-4E1E-A48D-7855D7A319C2

Q36835495-6AA822B1-FCC0-4CFB-A046-EE7891D947BA

Q36835495-C78A5C4C-729F-409B-A61C-58B2F5C21EF8

Q36835495-C93CE1A7-A88B-4A45-9952-5B1748AF8500

Q36835495-CCCD804A-B81B-4AE1-BBDF-39B904C8C7C4

Q36835495-E799A4AF-0ED7-42C2-806A-6FD203A6C8E6

P577

Q36835495-C25A63F5-FDF5-4CD9-B3CA-310D6F94EE93

P5875

Q36835495-C43D4E6B-1708-413C-B232-9212AA44F24A

P698

Q36835495-F2A136D5-D5A6-4FA3-B0AD-35E9BBB3A2C6

P921

Q36835495-572C6F67-9826-4072-B732-75993B92A554

Q36835495-AF7679FF-9AFE-4FC5-B865-69F27ECF1F8E

Q36835495-F575D443-318D-4F54-B86B-7BEFB83374D7

P932

Q36835495-FAB78A26-60AE-4F49-AACF-197BC7657D56

P356

PNAS.1220360110

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Protection against malaria aft ...... d by preerythrocytic immunity.

@en

P2093

André J A M van der Ven

http://www.w3.org/2001/XMLSchema#string

Anne C Teirlinck

http://www.w3.org/2001/XMLSchema#string

Annemieke Jansens

http://www.w3.org/2001/XMLSchema#string

Ben C L van Schaijk

http://www.w3.org/2001/XMLSchema#string

Cornelus C Hermsen

http://www.w3.org/2001/XMLSchema#string

Dunja Zimmerman

http://www.w3.org/2001/XMLSchema#string

Else M Bijker

http://www.w3.org/2001/XMLSchema#string

Guido J H Bastiaens

http://www.w3.org/2001/XMLSchema#string

Jaco J Verweij

http://www.w3.org/2001/XMLSchema#string

Jorien Wiersma

http://www.w3.org/2001/XMLSchema#string

P2860

A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines

Acquired immunity to malaria

Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs

Onset of clinical immunity to Plasmodium falciparum among Javanese migrants to Indonesian Papua.

Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.

Immunological processes in malaria pathogenesis.

Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans

A combined transcriptome and proteome survey of malaria parasite liver stages.

P304

7862-7867

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1220360110

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Lisette van Lieshout

Geert-Jan van Gemert

Marga van de Vegte-Bolmer

Rianne Siebelink-Stoter

Robert W Sauerwein

Edmond J Remarque

P577

2013-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236228375

http://www.w3.org/2001/XMLSchema#string

P698

23599283

http://www.w3.org/2001/XMLSchema#string

P921

P932

3651438

http://www.w3.org/2001/XMLSchema#string